Innovent’s phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Innovent’s phase 3 hits tee it up to challenge Amgen [...]
NIAID vaccine R&D director who collaborated with Moderna on COVID-19 vaccine to retire
NIAID vaccine R&D director who collaborated with Moderna on COVID-19 [...]
Gilead comes back around on Hookipa HIV partnership, signing away $15M upfront and more down the line
Gilead comes back around on Hookipa HIV partnership, signing away [...]
Sage, Biogen score on phase 3 depression trial, but we still don’t know about durability
Sage, Biogen score on phase 3 depression trial, but we [...]
Biotech pipeline is outpaced by antibacterial resistance, new BIO report says
Biotech pipeline is outpaced by antibacterial resistance, new BIO report [...]
A new SPAC decides to enter murky waters to hunt for biotechs in downsized $75M IPO
A new SPAC decides to enter murky waters to hunt [...]
IQVIA sees 2021 revenues jump 22% led by strong service growth
IQVIA sees 2021 revenues jump 22% led by strong service [...]
2seventy bio plucks Turnstone Biologics exec Bernstein to be new CMO
2seventy bio plucks Turnstone Biologics exec Bernstein to be new [...]
Improving RNA editing for genetic diseases by recruiting the body’s natural protein
Improving RNA editing for genetic diseases by recruiting the body’s [...]
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Roivant decants another Vant armed with Eisai blood cancer drug [...]